References
- Yarden Y, Kuang WJ, Yang-Feng T, et al : Human proto-oncogene c-kit : a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987 ; 6 : 3341-3351
- Lammie A, Drobnjak: M, Gerald W, Saad A, Cote R, Cordon-Cardo C : Expression ofc-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem 1994; 42 : 1417-1425 https://doi.org/10.1177/42.11.7523489
- Sekido Y, Obata Y, Ueda R, et al : Preferential expression of ckit protooncogene transcripts in small cell lung cancer. Cancer Res 1991 ; 51 : 2416-2419
- Pietsch T, Nicotra MR, Fraioli R, Wolf HK, Mottolese M, Natali PG : Expression of the c-kit receptor and its ligand SCF in nonsmall cell carcinomas. Int J Cancer 1998 ; 75 : 171-175 https://doi.org/10.1002/(SICI)1097-0215(19980119)75:2<171::AID-IJC1>3.0.CO;2-R
- Hirota S, Isozaki K, Moriyama Y, et al : Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279 : 577-580 https://doi.org/10.1126/science.279.5350.577
- Ikeda H, Kanakura Y, Tamaki T, et al : Expression and junctional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 1991 ; 78 : 2962-2968
- Hines SJ, Organ C, Komstein MJ, Krystal GW : Coexpression of the c-kit and stem cell factor genes in breast carcinomas. Cell Growth Differ 1995 ; 6 : 769-779
- Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M : Mutations in Exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999 ; 154: 53-60 https://doi.org/10.1016/S0002-9440(10)65250-9
- Longley BJ, Tyrrell L, Lu SZ, et al : Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis : establishment of clonality in a human mast cell neoplasm. Nat Genet 1996 ; 12 : 312-314 https://doi.org/10.1038/ng0396-312
- Jeng YM, Lin CY, Hsu HC : Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett 2000 Jun 1 ; 154(1) : 107-111 https://doi.org/10.1016/S0304-3835(00)00387-6
- Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr : KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 1999 Oct; 12 (10) : 956-960
- Ehab YH, James YS : Neoplasms of the Salivary Glands. In : Cummings CW, Fredricson JM, Harker LA, et al (eds). Otolaryngology-Head and Neck Surgery, 3rd Ed. St. Louis : Mosby-Year Book, 1998, p1255-1302
- Pignataro L, Capaccio P, Carboni N, et al : p53 and cyclinX D1 protein expression in carcinomas of the parotid gland. Anticancer Res 1998 ; 18 : 1287-1290
- Deguchi H, Hamano H, Hayashi Y : c-myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands. Acta Pathol Jpn 1993 ; 43 : 413-422
- Kamio N : Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumour stage, and cell proliferation in malignant salivary gland tumours. Virchows Archiv 1996 ; 428: 75-83
- Gallo O, Franchi A, Bianchi S, Boddi V, Giannelli E, Alajmo E : p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer 1995 ; 75 : 2037-2044 https://doi.org/10.1002/1097-0142(19950415)75:8<2037::AID-CNCR2820750802>3.0.CO;2-V
- Sarlomo-Rikata M, Kovatich AJ, Barusevicius A, Miettine M : CD117 : a sensitive marker for gastrointestinal stromal tumors that is specific than CD34. Mod Pathol 1998 ; 11 : 728-734
- Tazawa K, Tsukada K, Makuuchi H, Tsutsumi Y : An immuno-histochemical and clinico-pathological study of gastrointestinal tumors. Pathol Int 1999 ; 49 : 786-798 https://doi.org/10.1046/j.1440-1827.1999.00947.x
- Demetri GD : Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571). Eur J Cancer 2002 Sep ; 38 Suppl 5 : S52-59